Brief: Enlivex Receives Notice Of Allowance For Japanese Patent Application Covering The Use Of Allocetra In Patients With Osteoarthritis
30/10/2024 13:10
Oct 30 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX RECEIVES NOTICE OF ALLOWANCE FOR JAPANESE PATENT
APPLICATION COVERING THE USE OF ALLOCETRA™ IN PATIENTS WITH
OSTEOARTHRITIS
* ENLIVEX THERAPEUTICS LTD - PATENT EXPECTED TO BE ISSUED IN
JAPAN
BY Q2 2025
Source text: ID:nGNXb3sXsy
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment